Fiona E. Scott

417 total citations
23 papers, 221 citations indexed

About

Fiona E. Scott is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Fiona E. Scott has authored 23 papers receiving a total of 221 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Molecular Biology. Recurrent topics in Fiona E. Scott's work include Radiopharmaceutical Chemistry and Applications (9 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Fiona E. Scott is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (9 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Fiona E. Scott collaborates with scholars based in Australia, United States and United Kingdom. Fiona E. Scott's co-authors include Andrew M. Scott, Angela Rigopoulos, Ingrid J.G. Burvenich, Owen Epstein, Graeme O’Keefe, Christoph Renner, Andrew K. Burroughs, Peter J. Scheuer, P. Aiden McCormick and Neil McIntyre and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Hepatology.

In The Last Decade

Fiona E. Scott

21 papers receiving 219 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fiona E. Scott Australia	9	106	60	42	35	33	23	221
Harsh Bahrar Netherlands	6	109 1.0×	29 0.5×	71 1.7×	93 2.7×	42 1.3×	9	213
Xiaoqing Xu China	12	126 1.2×	46 0.8×	105 2.5×	18 0.5×	67 2.0×	28	298
Angelo Dipasquale Italy	9	66 0.6×	19 0.3×	55 1.3×	25 0.7×	36 1.1×	23	217
Stephanie O. Dudzinski United States	5	126 1.2×	37 0.6×	68 1.6×	132 3.8×	46 1.4×	12	268
Xianwen Hu China	8	53 0.5×	51 0.8×	39 0.9×	12 0.3×	39 1.2×	46	179
Judy Nguyen United States	7	79 0.7×	55 0.9×	66 1.6×	14 0.4×	24 0.7×	14	244
Nicolas Whenham Belgium	7	82 0.8×	29 0.5×	87 2.1×	17 0.5×	64 1.9×	17	234
Ali Hussain United States	5	65 0.6×	18 0.3×	129 3.1×	40 1.1×	55 1.7×	5	278
Zuguang Xia China	10	160 1.5×	21 0.3×	97 2.3×	46 1.3×	34 1.0×	33	314

Countries citing papers authored by Fiona E. Scott

Since Specialization

Citations

This map shows the geographic impact of Fiona E. Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fiona E. Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fiona E. Scott more than expected).

Fields of papers citing papers by Fiona E. Scott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fiona E. Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fiona E. Scott. The network helps show where Fiona E. Scott may publish in the future.

Co-authorship network of co-authors of Fiona E. Scott

This figure shows the co-authorship network connecting the top 25 collaborators of Fiona E. Scott. A scholar is included among the top collaborators of Fiona E. Scott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fiona E. Scott. Fiona E. Scott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hawkes, Eliza A., Jodie Palmer, Richard Khor, et al.. (2025). T-cell dysregulation informs radiotherapy-immunotherapy response in B-cell lymphoma: results from a phase 1 trial. Blood Advances. 9(20). 5263–5273.

Parakh, Sagun, Deliang Cao, Angela Rigopoulos, et al.. (2025). Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2. Molecular Cancer Therapeutics. 24(9). 1442–1452. 1 indexed citations

Parakh, Sagun, Deliang Cao, Angela Rigopoulos, et al.. (2025). Data from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2. 1 indexed citations

Johnstone, Cameron N., Laura D. Osellame, Zhipeng Cao, et al.. (2025). DNA-Dependent Protein Kinase Inhibitor Peposertib Enhances Efficacy of¹⁷⁷Lu-Based Radioimmunotherapy in Preclinical Models of Prostate and Renal Cell Carcinoma. Journal of Nuclear Medicine. 66(3). 385–390. 3 indexed citations

Parakh, Sagun, Nhi Huynh, Laura D. Osellame, et al.. (2025). Characterisation of mAb104 Antibody–Drug Conjugates Targeting a Tumour-Selective HER2 Epitope. Cancers. 17(18). 2995–2995. 1 indexed citations

Robinson, Luke, Andrew Murray, Margo Mountjoy, et al.. (2025). Associations Between Physical Performance and Golf Shot Data: A Pilot Study of Touring Professional Female Players. The Journal of Strength and Conditioning Research. 39(6). 687–694.

Burvenich, Ingrid J.G., Christian Wichmann, Angela Rigopoulos, et al.. (2024). Targeting of immune checkpoint regulator V-domain Ig suppressor of T-cell activation (VISTA) with 89Zr-labelled CI-8993. European Journal of Nuclear Medicine and Molecular Imaging. 51(13). 3863–3873. 2 indexed citations

Cao, Zhipeng, Christian Wichmann, Ingrid J.G. Burvenich, et al.. (2024). Radiolabelling and preclinical characterisation of [89Zr]Zr-Df-ATG-101 bispecific to PD-L1/4–1BB. European Journal of Nuclear Medicine and Molecular Imaging. 51(11). 3202–3214. 4 indexed citations

Janes, Peter W., Adam Parslow, Diana Cao, et al.. (2024). An Anti-VEGF-B Antibody Reduces Abnormal Tumor Vasculature and Enhances the Effects of Chemotherapy. Cancers. 16(10). 1902–1902. 8 indexed citations

10.

Wichmann, Christian, Ingrid J.G. Burvenich, Angela Rigopoulos, et al.. (2023). Preclinical radiolabeling, in vivo biodistribution and positron emission tomography of a novel pyrrolobenzodiazepine (PBD)-based antibody drug conjugate targeting ASCT2. Nuclear Medicine and Biology. 122-123. 108366–108366. 5 indexed citations

11.

Burvenich, Ingrid J.G., Hui Gan, Angela Rigopoulos, et al.. (2021). Radiolabelling and preclinical characterization of 89Zr-Df-radiolabelled bispecific anti-PD-L1/TGF-βRII fusion protein bintrafusp alfa. European Journal of Nuclear Medicine and Molecular Imaging. 48(10). 3075–3088. 20 indexed citations

12.

Scott, Fiona E., Christian Wichmann, Ingrid J.G. Burvenich, et al.. (2021). 324 Preclinical evaluation of anti-VISTA antibody CI-8993 in a syngeneic huVISTA-KI model. SHILAP Revista de lepidopterología. 6 indexed citations

13.

Chia, Puey Ling, Sagun Parakh, Prudence A. Russell, et al.. (2020). Expression of EGFR and conformational forms of EGFR in malignant pleural mesothelioma and its impact on survival. Lung Cancer. 153. 35–41. 11 indexed citations

14.

Burvenich, Ingrid J.G., Sagun Parakh, Fook-Thean Lee, et al.. (2018). Molecular imaging of T cell co-regulator factor B7-H3 with ⁸⁹Zr-DS-5573a. Theranostics. 8(15). 4199–4209. 41 indexed citations

15.

Li, Hong, Manuel Zeitelhofer, Ingrid Nilsson, et al.. (2018). Development of monoclonal anti-PDGF-CC antibodies as tools for investigating human tissue expression and for blocking PDGF-CC induced PDGFRα signalling in vivo. PLoS ONE. 13(7). e0201089–e0201089. 8 indexed citations

16.

Baird, Sarah K., et al.. (2015). Fibroblast activation protein increases metastatic potential of fibrosarcoma line HT1080 through upregulation of integrin-mediated signaling pathways. Clinical & Experimental Metastasis. 32(5). 507–516. 24 indexed citations

17.

Baird, Sarah K., Angela Rigopoulos, Diana Cao, et al.. (2015). Integral membrane protease fibroblast activation protein sensitizes fibrosarcoma to chemotherapy and alters cell death mechanisms. APOPTOSIS. 20(11). 1483–1498. 7 indexed citations

18.

Herbertson, Rebecca, Niall C. Tebbutt, Fook-Thean Lee, et al.. (2014). Targeted Chemoradiation in Metastatic Colorectal Cancer: A Phase I Trial of ¹³¹I-huA33 with Concurrent Capecitabine. Journal of Nuclear Medicine. 55(4). 534–539. 24 indexed citations

19.

Scott, Fiona E., Andrea Mechelli, Matthew Allin, et al.. (2011). Very preterm adolescents show gender-dependent alteration of the structural brain correlates of spelling abilities. Neuropsychologia. 49(9). 2685–2693. 11 indexed citations

20.

McCormick, P. Aiden, Fiona E. Scott, Owen Epstein, et al.. (1994). Thalidomide as therapy for primary biliary cirrhosis: a double-blind placebo controlled pilot study. Journal of Hepatology. 21(4). 496–499. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact